1.92
前日終値:
$1.92
開ける:
$1.92
24時間の取引高:
59,823
Relative Volume:
0.03
時価総額:
$121.25M
収益:
$2.72M
当期純損益:
$-85.08M
株価収益率:
-0.9948
EPS:
-1.93
ネットキャッシュフロー:
$-70.93M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-19.67%
6か月 パフォーマンス:
+94.14%
1年 パフォーマンス:
+52.38%
Shattuck Labs Inc Stock (STTK) Company Profile
STTK を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
STTK
Shattuck Labs Inc
|
1.92 | 91.97M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-08 | 開始されました | Wedbush | Outperform |
| 2025-03-17 | 開始されました | Leerink Partners | Outperform |
| 2024-10-02 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-10-02 | ダウングレード | Needham | Buy → Hold |
| 2024-10-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-08-31 | 開始されました | BTIG Research | Buy |
| 2022-06-01 | 開始されました | Citigroup | Buy |
| 2022-05-02 | 開始されました | H.C. Wainwright | Buy |
| 2021-04-14 | 開始されました | Berenberg | Buy |
| 2021-01-11 | 開始されました | Evercore ISI | Outperform |
| 2020-11-03 | 開始されました | Citigroup | Buy |
| 2020-11-03 | 開始されました | Cowen | Outperform |
| 2020-11-03 | 開始されました | Needham | Buy |
すべてを表示
Shattuck Labs Inc (STTK) 最新ニュース
Visual analytics tools that track Shattuck Labs Inc. performance2025 Short Interest & Real-Time Chart Pattern Alerts - newser.com
Long term hold vs stop loss in Shattuck Labs Inc.July 2025 Market Mood & AI Based Buy/Sell Signal Reports - newser.com
How geopolitical tensions affect Shattuck Labs Inc. stockWeekly Volume Report & Technical Pattern Recognition Alerts - newser.com
How to manage a losing position in Shattuck Labs Inc.Weekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com
Will Shattuck Labs Inc. stock go up soonWeekly Trend Summary & Daily Volume Surge Signals - newser.com
Does Shattuck Labs Inc. qualify in momentum factor screeningTrade Entry Report & Fast Moving Trade Plans - newser.com
What moving averages say about Shattuck Labs Inc.2025 Technical Overview & Reliable Breakout Forecasts - newser.com
How Shattuck Labs Inc. stock performs during Fed tightening cyclesMarket Growth Summary & Verified Entry Point Detection - newser.com
Is Shattuck Labs Inc. stock attractive for retirement portfoliosTrade Volume Summary & Entry Point Strategy Guides - newser.com
How institutional buying supports Shattuck Labs Inc. stockJuly 2025 Final Week & Real-Time Volume Spike Alerts - newser.com
Shattuck Labs (STTK) Price Target Increased by 15.61% to 2.72 - Nasdaq
Will Shattuck Labs Inc. stock reach Wall Street targetsLayoff News & Risk Controlled Stock Pick Alerts - newser.com
How strong is Shattuck Labs Inc. stock balance sheetSwing Trade & Risk Managed Investment Signals - Fundação Cultural do Pará
Shattuck Labs, Inc. (NASDAQ:STTK) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Performance Recap: How Shattuck Labs Inc. stock benefits from global expansionQuarterly Profit Review & Expert Curated Trade Setup Alerts - Fundação Cultural do Pará
Shattuck Labs’ SL-325 Phase 1 Trial: A Key Development in Biopharmaceuticals - TipRanks
Weiss Ratings Reiterates "Sell (D-)" Rating for Shattuck Labs (NASDAQ:STTK) - MarketBeat
Shattuck Labs Inc (STTK) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):